Back to SYRE

TCG Crossover Management, LLC → SYRE

TCG Crossover Management, LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$169.2M
Q3 2026
Peak value
$169.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$62.3M
Q1 2026$95.9M
Q2 2026$168.7M
Q3 2026$169.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$169.2M1.90M——
Q2 2026$168.7M1.90M——
Q1 2026$95.9M1.90M——
Q4 2025$62.3M1.90M——

Other funds holding SYRE

Other TCG Crossover Management, LLC positions

AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$959M
AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$800.6M
AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$721.7M
AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$362.7M
TNGX

TANGO THERAPEUTICS INC

$283.9M
CGON

CG ONCOLOGY INC

$260.8M
CGON

CG ONCOLOGY INC

$260.2M
CGON

CG ONCOLOGY INC

$248.4M